Intravenous methadone in the management of chronic cancer pain: safe and effective starting doses when substituting methadone for fentanyl.

作者: Juan Santiago-Palma , Natalia Khojainova , Craig Kornick , Daniel J. Fischberg , Louis H. Primavera

DOI: 10.1002/1097-0142(20011001)92:7<1919::AID-CNCR1710>3.0.CO;2-G

关键词:

摘要: BACKGROUND Patients often are rotated from other opioids to methadone when side effects occur before satisfactory analgesia is achieved. Various strategies have been proposed estimate safe and effective starting doses of rotating morphine hydromorphone; however, there no guidelines for estimating fentanyl. METHODS The authors prospectively observed 18 consecutive patients experiencing chronic pain cancer who underwent opioid rotation intravenous patient-controlled (PCA) with fentanyl PCA methadone. Patients were switched because uncontrolled associated sedation or confusion. A conversion ratio 25 μg/hour 0.1 mg/hour was used calculate the initial dose in all patients. RESULTS Mean scores decreased 8.1 4.8 on Day 1 after switch 3.22 4 switch. Mean 1.5 0.44 0.16 Days 4, respectively. Among 6 experienced confusion while switch, 5 improved within 2 days None toxicity methadone. CONCLUSIONS On basis this preliminary study, suggest that switching a may be effective. Cancer 2001;92:1919–25. © 2001 American Society.

参考文章(17)
Eduardo Bruera, Catherine M. Neumann, Role of methadone in the management of pain in cancer patients. Oncology. ,vol. 13, pp. 1275- 1282 ,(1999)
Sebastiano Mercadante, Alessandra Casuccio, Luciano Calderone, Rapid Switching From Morphine to Methadone in Cancer Patients With Poor Response to Morphine Journal of Clinical Oncology. ,vol. 17, pp. 3307- 3312 ,(1999) , 10.1200/JCO.1999.17.10.3307
K M Foley, R W Houde, Methadone in cancer pain management: individualize dose and titrate to effect. Journal of Clinical Oncology. ,vol. 16, pp. 3213- 3215 ,(1998) , 10.1200/JCO.1998.16.10.3213
C Ripamonti, L Groff, C Brunelli, D Polastri, A Stavrakis, F De Conno, Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? Journal of Clinical Oncology. ,vol. 16, pp. 3216- 3221 ,(1998) , 10.1200/JCO.1998.16.10.3216
Katherine R. Edwards, Charles S. Cleeland, Ronald C. Serlin, Tito R. Mendoza, Yoshio Nakamura, When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. ,vol. 61, pp. 277- 284 ,(1995) , 10.1016/0304-3959(94)00178-H
Robin Fainsinger, Teresa Schoeller, Eduardo Bruera, Methadone in the management of cancer pain: a review Pain. ,vol. 52, pp. 137- 147 ,(1993) , 10.1016/0304-3959(93)90125-9
Bradley S. Galer, Nessa Coyle, Gavril W. Pasternak, Russell K. Portenoy, Individual variability in the response to different opioids: report of five cases☆ Pain. ,vol. 49, pp. 87- 91 ,(1992) , 10.1016/0304-3959(92)90192-E
J MORLEY, Methadone in pain uncontrolled by morphine. The Lancet. ,vol. 342, pp. 1243- 1243 ,(1993) , 10.1016/0140-6736(93)92228-L